The Medical Letter on Drugs and Therapeutics
Drugs for Rosacea
February 1, 2016 (Issue: 1487)This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops of acneiform papules and...more
- LK Oge' et al. Rosacea: diagnosis and treatment. Am Fam Physician 2015; 92:187.
- Brimonidine gel (Mirvaso) for rosacea. Med Lett Drugs Ther 2013; 55:82.
- ET Routt and JO Levitt. Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%. J Am Acad Dermatol 2014; 70:e37.
- D Ilkovitch and RG Pomerantz. Brimonidine effective but may lead to significant rebound erythema. J Am Acad Dermatol 2014; 70:e109.
- Ivermectin cream (Soolantra) for rosacea. Med Lett Drugs Ther 2015; 57:51.
- A Taieb et al. Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol 2015; 172:1103.
- A low-dose doxycycline (Oracea) for rosacea. Med Lett Drugs Ther 2007; 49:5.
- JQ Del Rosso et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies. Cutis 2014; 93:18.
- E Tanghetti et al. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices. Cutis 2014; 93:71.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.